Between 1985 and 2002, population-based data from Germany demonstrated significant declines in AMI morbidity and IHD mortality, largely driven by reductions in recurrent events and 28-day case fatality due to intensified reperfusion and evidence-based medical therapies.
No takes yet. Share an insight, caveat, or question.
Supports evidence-based IHD therapies from population trends; Level 3 cohort data leaves causality open.
Löwel et al. (2005) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: